PATENT CLAIM ANALYSIS

Application Number: 15770737
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["514", "356000"]

Abstract:
The present specification provides methods of treating nervous system disorders with a thyroid hormone neutral dose of a RXR agonist to promote remyelination or neuroprotection or both and thereby maintain or regenerate healthy axons and neurons.

Claim (Index 12):
The method according to  claim 1 , wherein treatment with the thyroid hormone neutral dose of RXR agonist reduces at least one symptom of the nervous system disorder, wherein the one symptom reduced is inflammation, fatigue, dizziness, headache, malaise, elevated fever and high body temperature, extreme sensitivity to cold in the hands and feet, weakness and stiffness in muscles and joints, weight changes, digestive or gastrointestinal problems, low or high blood pressure, irritability, anxiety, or depression, blurred or double vision, ataxia, clonus, dysarthria, fatigue, clumsiness, hand paralysis, hemiparesis, genital anesthesia, incoordination, paresthesias, ocular paralysis, impaired muscle coordination, weakness (muscle), loss of sensation, impaired vision, neurological symptoms, unsteady gait, spastic paraparesis, incontinence, hearing problems, or speech problems.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 91.0
- Lexical Diversity: 1.15625
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15812821', '15339752', '15339762', '14507730', '10477876']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8565533317148816
- 35 USC 102 Novelty (BERT): 0.6422766310344953
- Combined Prediction Score: 0.835125661646843
- Mean Citation Score: 525.456226
- Max Citation Score: 623.54266
- Similarity Product: 535.5136335715126

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test